IL1RL2 and myocardial infarction: A new mechanistic role for the IL-36/IL-36R signalling pathway is described for the first time in this co-morbidity model of MI, inhibition of which reassuringly remained vasculoprotective even in the highly inflamed hearts of injured HFD mice.